Exane Derivatives’s Emergent Biosolutions EBS Stock Holding History

Exane Derivatives’s Portfolio EBS Stock Details EBS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.21K	Sell
2022 Q1	$51.1K	Sell
2021 Q4	$72.6K	Sell
2021 Q3	$101K	Sell
2021 Q2	$137K	Sell
2021 Q1	$290K	Sell
2020 Q4	$394K	Buy